A Cost-benefit Analysis of Colposcopy for Cervical Squamous Intraepithelial Lesions Found on Papanicolaou Smear

Archives of Family Medicine

Volumn 5, Issue 10, 1996, Pages 576-581

  Chesebro, Marcia J ^a,b   Everett, W Douglas ^a  

^a UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COLPOSCOPY; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ECONOMICS; FEMALE; HUMAN; MASS SCREENING; MIDDLE AGED; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030294302     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.5.10.576     Document Type: Article

References (36)

1. Centers for Disease Control. Cervical cancer control - Rhode Island. MMWR Morb Mortal Wkly Rep. 1989;38:659-662.
2. Devesa SS, Silverman DT, Young JL, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987; 79:701-770.
3. Public Health Service. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: US Dept of Health and Human Services, Public Health Service; 1990.
4. Mitchell H, Medley G. Age and time trends in the prevalence of cervical intraepithelial neoplasia on Papanicolaou smear tests: 1970-1988. Med J Aust. 1990;152:252.
5. Sedlacek TV. Clinical options in dealing with minor cytologic abnormalities. Colposcopist. 1992;24(4):1-2.
6. Weinstein MC, Fineberg HV, eds. Clinical Decision Analysis. Philadelphia, Pa: WB Saunders Co; 1980:228-265.
7. Kashigarian M, Dunn JE. The duration of intraepithelial and preclinical squamous cell carcinoma of the uterine cervix. Am J Epidemiol. 1970;92:211-222.
8. Kottmeier HL. Evolution et traitement des epitheliomas. Rev Fr Gynecol Obstet. 1961;56:821-826.
9. Gad C. The management and natural history of severe dysplasia and carcinoma in situ of the uterine cervix. Br J Obstet Gynaecol. 1976;83:554-559.
10. Jordan MJ, Bader GM, Day E. Carcinoma in situ of the cervix and related lesions: an 11 year prospective study. Am J Obstet Gynecol. 1964;89:160-182.
11. Koss LG, Stewart FW, Foote FW, et al. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix: a long-term prospective study. Cancer. 1963;16:1160-1211.
12. Murphy WM, Coleman SA. The long-term course of carcinoma in situ of the uterine cervix. Cancer. 1976;38:957-963.
13. US Dept of Health and Human Services. Advance report of final mortality statistics, 1989. CDC Monthly Vital Stat Rep. 1992;40:1.
14. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113:214-226.
15. Everett WD, Solomon P, Wheeler L. Experience with colposcopy in a family practice center. Fam Pract Res J. 1991;11:283-290.
16. Centers for Disease Control. Results from the national breast and cervical cancer early detection program, October 31, 1991-September 30, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:530-534.
17. Cervical Cytology: Evaluation and Management of Abnormalities. Washington, DC: American College of Obstetricians and Gynecologists; 1993:1-8. ACOG Technical Bulletin 183.
18. Montz FJ, Monk BJ, Fowler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol. 1992;80:385-388.
19. Carmichael JA, Maskens PD. Cervical dysplasia and human papilloma virus. Am J Obstet Gynecol. 1989;160:916-918.
20. American Cancer Society Report: the cancer related health checkup. CA Cancer J Clin. 1980;30:215-223.
21. Wright VC, Riopelle MA. Age at beginning of coitus versus chronologic age as a basis for Papanicolaou smear screening: an analysis of 747 cases of preinvasive disease. Am J Obstet Gynecol. 1984;149:824-830.
22. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 1983;61:609-614.
23. Walton Report: cervical cancer screening programs. Can Med Assoc J. 1976; 114:1003-1031.
24. Richart RM, Barron BA. Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer. 1981;47:1176-1181.
25. Wright TC, Gagnon S, Richart RM, Ferenczy A. Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure. Obstet Gynecol. 1992;79:173-178.
26. Ostergard DR. Cryosurgical treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 1980;56:231.
27. Hatch KD, Shingleton HM, Austin JM Jr, Soong SJ, Bradley DH. Cryosurgery of cervical intraepithelial neoplasia. Obstet Gynecol. 1981;57:692.
28. Levine RU, Carillo EJ, Crum CP. Outpatient management of cervical intraepithelial neoplasia: a summary of 279 cases. J Reprod Med. 1985;30:351.
29. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation. 1982;66(suppl 111):56-66.
30. Weinstein MC, Stason WB. Hypertension: A Policy Perspective. Cambridge, Mass: Harvard University Press; 1976.
31. Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 1994;154:1143-1149.
32. Goldman L. Cost awareness in medicine. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Medicine. 13th ed. New York, NY: McGraw-Hill International Book Co; 1994: 40-41.
33. Eddy D, Hasselblad V, McGivney W, Hendle W. The value of mammography screening in women under age 50 years. JAMA. 1988;259:1512-1519.
34. Goldman L, Goldman PA, Williams LW, Weinstein MC Cost-effectiveness considerations in the treatment of heterozygous familial hypercholesterolemia with medications. Am J Cardiol. 1993;72:75D-79D.
35. Eddy DM. The frequency of cervical cancer screening: comparison of a mathematical model with empirical data. Cancer. 1987;60:1117-1122.
36. Shy K, Chu J, Mandelson M, et al. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol. 1989;74:838-843.